Auto logout in seconds.
Continue LogoutAccording to a new report from the American Medical Association (AMA), many doctors recognize the potential value of health data from wearable technology, but structural barriers to adoption make it more difficult to leverage the data effectively.
For the report, AMA surveyed 2,222 physicians from the United States, Canada, and several European countries between January and March 2026 about how they viewed and used consumer digital wearable devices in their practices.
Consumer digital wearable devices refer to nonprescription, commercial devices that individuals use to track their personal health, fitness, and performance. These devices include smartwatches, fitness trackers, and biosensors.
According to the report, many physicians already use wearable devices personally, with 82% saying they used a smartwatch, fitness tracker, or other technology. As part of their clinical practice, physicians across different countries reported similar levels of exposure to and interest in wearable data, with only 3% saying they never reviewed at least one type of wearable data.
In the United States, the top wearable data categories reviewed by physicians were activity and function, heart physiology, events and alerts, and sleep. These were also the top reviewed categories in most markets.
Many physicians also reported seeing at least some clinical advantage in wearable data. Seventy-seven percent of U.S. physicians said there was at least some clinical advantage in wearable data, while 74% of physicians outside the United States said the same.
"Providers should know: Has the device been clinically validated? In what population? Under what circumstances? And that should be stratified based upon risk in terms of what it's assessing,"
Since wearable technology is still emerging, patients do not routinely ask physicians to review data from their health-related devices. Based on a review of the past three months, only 16% of physicians said patients asked them to review wearable data at least weekly. Similarly, only 15% to 23% of physicians said patients explicitly asked them to incorporate wearable data into their care plans, sought guidance about wearable data, or asked physicians to interpret wearable data on a weekly basis.
However, when patients ask physicians to review wearable data, they typically will, showing that "[e]ven though demand remains limited, the relationship between patient request and physician action is strong," AMA writes.
Although interest in wearable technology is growing among both physicians and patients, very few countries have integrated wearable data into clinical practice and workflows. Currently, only 6% of U.S. physicians said wearable data is integrated into their clinical workflows, and less than 20% said it was very or extremely likely that wearable data would be integrated within the next 12 months.
"Physicians are interested in the data just as consumers are, and the challenge is the technology of healthcare [systems] that don't have a way to incorporate it into physician workflow," said AMA CEO John Whyte.
According to the report, how the review of patient-generated data, including data from wearables, is supported and paid for in clinical care varies by country, which can impact how often physicians review wearable data. In the United States, current reimbursement pathways are not designed to be used with consumer wearable data and typically do not apply to them. Only 10% of U.S. physicians said they used CPT billing codes for remote patient monitoring, but these codes require the use of FDA-approved devices with a clinician-directed plan of care rather than data from consumer wearable devices.
Physicians also reported concerns about legal liability and the potential feasibility of using wearable data in clinical practice. Among U.S. physicians, 43% said the top barrier was medical-legal concerns, while 33% said the top barrier was accuracy and 29% said it was outcomes evidence.
In addition, 44% of U.S. physicians said regulatory approval was strong or essential for trust in wearable accuracy. Currently, regulation of wearable devices is mixed, with devices promoted as wellness tools generally receiving lighter oversight.
"There needs to be a process where we can see the evidence and there's standards and transparency," said Whyte. Providers should know: Has the device been clinically validated? In what population? Under what circumstances? "And that should be stratified based upon risk in terms of what it's assessing," Whyte noted.
(Reed, Axios, 7/8; AMA Multi-Country Study on Consumer Wearable Data in Clinical Practice, accessed 7/13; Olsen, Healthcare Dive, 7/8; Landi, Fierce Healthcare, 7/13)
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.